The subject expert committee had given conditional nod to both the
vaccines and these were awaiting the drug regulator's approval.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-regulator-approves-siis-covishield-and-bharat-biotechs-covaxin-for-restrictive-use-in-emergency-situation/articleshow/80080393.cms
No comments:
Post a Comment